|Bid||74.44 x 900|
|Ask||74.86 x 900|
|Day's Range||73.40 - 75.56|
|52 Week Range||65.25 - 87.80|
|Beta (5Y Monthly)||0.43|
|PE Ratio (TTM)||26.68|
|Earnings Date||Apr 29, 2021|
|Forward Dividend & Yield||2.60 (3.51%)|
|Ex-Dividend Date||Mar 12, 2021|
|1y Target Est||96.33|
Dr. Sonja Santelises, CEO of Baltimore City Public Schools, joins Yahoo Finance’s Alexis Christoforous and Akiko Fujita to discuss the push to reopen schools and women in education.
Val Ackerman, Commissioner of the Big East, joins Yahoo Finance’s Julie Hyman and Alexis Christoforous to discuss March Madness amid the pandemic.
A controversial Alzheimer's drug that has weighed on Biogen stock this year could ultimately become a major blockbuster within five years, a market research group predicted Tuesday.